CV Sciences, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2022-03-31

Quarterly Report for period ending 2021-09-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Application for designation of a new trustee under the Trust Indenture Act

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

Order Granting Confidential Treatment

Exempt (Private) Offering

Withdrawal of amendment to a registration statement filed under the Securities Act

Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement

Exempt (Private) Offering

Exempt (Private) Offering

Dowling Joseph D: Statement of changes in beneficial ownership of securities

Grasser Joerg: Statement of changes in beneficial ownership of securities

McCorkle William: Statement of changes in beneficial ownership of securities

McCorkle William: Initial statement of beneficial ownership of securities

Corroon James Michael Jr.: Statement of changes in beneficial ownership of securities

Corroon James Michael Jr.: Initial statement of beneficial ownership of securities

Dowling Joseph D: Statement of changes in beneficial ownership of securities

Grasser Joerg: Statement of changes in beneficial ownership of securities

BLAKE PAUL: Statement of changes in beneficial ownership of securities

MAROON JOSEPH C MD: Statement of changes in beneficial ownership of securities

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Registration statement for specified transactions by certain issuers

Registration Withdrawal Request

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Definitive proxy statements

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.